USA – Woodcock takes charge as acting FDA commissioner

Janet Woodcock, the long-serving director of the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), is officially the agency’s acting commissioner and is reportedly being considered for the Biden administration’s permanent pick for the role.
 
Hours after the presidential inauguration, Woodcock tweeted, “It is an honor and privilege” to serve as acting commissioner. “The FDA’s public health work is more critical than ever as we continue to fight this global pandemic,” she wrote. Both the FDA and HHS leadership webpages have been updated to reflect Woodcock’s acting role.
 
“This has been a very tough year, and we have a challenging road ahead. I know you all have endured hardships while carrying out our public health mission, balancing work and family, and trying to stay safe. It has not gone unnoticed,” Woodcock wrote in a note to FDA staff…